Welcome to LookChem.com Sign In|Join Free
  • or
MEOSUC-GLU-VAL-LYS-MET-PNA is a peptide that consists of the amino acid sequence methionine, glutamic acid, valine, lysine, and methionine conjugated to 2-methoxyethoxysuccinyl (MEOSUC). This chemical compound is notable for its potential applications in targeted drug delivery systems and peptide-based therapeutics, owing to its ability to specifically bind to target molecules and receptors in biological systems. The unique sequence and conjugation of MEOSUC-GLU-VAL-LYS-MET-PNA make it a promising candidate for the design of novel pharmaceuticals and biomedical research tools.

138486-85-8

Post Buying Request

138486-85-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

138486-85-8 Usage

Uses

Used in Pharmaceutical Development:
MEOSUC-GLU-VAL-LYS-MET-PNA is used as a building block for the development of targeted drug delivery systems. Its specific binding capabilities allow for the precise targeting of therapeutic agents to particular cells or tissues, enhancing the efficacy and reducing the side effects of treatments.
Used in Peptide-based Therapeutics:
MEOSUC-GLU-VAL-LYS-MET-PNA is utilized as a component in the creation of peptide-based therapeutics. The peptide's unique sequence and conjugation can be harnessed to develop new drugs that can modulate biological processes at the molecular level, offering innovative treatment options for various diseases.
Used in Biomedical Research:
MEOSUC-GLU-VAL-LYS-MET-PNA serves as a valuable tool in biomedical research. Its ability to bind specifically to target molecules and receptors makes it useful for studying the interactions between drugs and biological systems, as well as for the development of new diagnostic and therapeutic approaches.
Used in Drug Delivery Systems:
In the field of drug delivery, MEOSUC-GLU-VAL-LYS-MET-PNA is used as a targeting moiety for enhancing the specificity and efficiency of drug delivery. This can lead to improved therapeutic outcomes and reduced side effects by ensuring that drugs reach their intended targets more effectively.
Used in Bioconjugation:
MEOSUC-GLU-VAL-LYS-MET-PNA is used as a bioconjugation agent to attach drugs, imaging agents, or other molecules to specific biological targets. This can facilitate the development of conjugated systems with enhanced functionality, such as targeted drug delivery or biosensing applications.
Used in the Development of Novel Pharmaceuticals:
MEOSUC-GLU-VAL-LYS-MET-PNA is employed as a key component in the design and synthesis of novel pharmaceuticals. Its unique properties and sequence can be leveraged to create new drugs with improved targeting, efficacy, and safety profiles.

Check Digit Verification of cas no

The CAS Registry Mumber 138486-85-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,4,8 and 6 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 138486-85:
(8*1)+(7*3)+(6*8)+(5*4)+(4*8)+(3*6)+(2*8)+(1*5)=168
168 % 10 = 8
So 138486-85-8 is a valid CAS Registry Number.

138486-85-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name MeOSuc-Glu-Val-Lys-Met-pNa

1.2 Other means of identification

Product number -
Other names MEOSUC-GLU-VAL-LYS-MET-PNA

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:138486-85-8 SDS

138486-85-8Upstream product

138486-85-8Downstream Products

138486-85-8Relevant academic research and scientific papers

Chymotrypsin-like proteases and their inhibitors

-

, (2008/06/13)

Methods are disclosed for the detection of proteases indicative of Alzheimer's disease which are capable of cleaving β-amyloid precursor protein between methionine and aspartic acid residues. Inhibitors and substrates for these enzymes are also described

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 138486-85-8